Nuvectis Pharma, Inc.
NVCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001875558
No open-market purchases or sales by Nuvectis Pharma, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $189.0M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Nuvectis Pharma, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 33 | 47 | +14 |
| Shares | 2.05M | 3.24M | +1.20M (+58.4%) |
| Value | $20.0M | $24.2M | +$4.16M (+20.8%) |
New holders (22)
Institutions that held Nuvectis Pharma, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 45,274 | $338.2K | 0.00% |
| Renaissance Technologies LLC | 43,000 | $321.2K | 0.00% |
| Charles Schwab Investment Management Inc | 37,982 | $283.7K | 0.00% |
| Royal Bank of Canada | 31,232 | $233.0K | 0.00% |
| Bank of New York Mellon Corp | 27,239 | $203.5K | 0.00% |
| Nuveen, LLC | 16,749 | $125.1K | 0.00% |
| Marex Group plc | 15,000 | $112.0K | 0.00% |
| New York State Common Retirement Fund | 13,000 | $97.1K | 0.00% |
| Deutsche Bank AG | 12,950 | $96.7K | 0.00% |
| Rhumbline Advisers | 12,678 | $94.7K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 7,029 | $52.5K | 0.00% |
| Wells Fargo & Company | 6,653 | $49.7K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 3,785 | $28.3K | 0.00% |
| Simplex Trading, LLC | 2,114 | $15.0K | 0.00% |
| Legal & General Group Plc | 1,434 | $10.7K | 0.00% |
| Ameritas Investment Partners, Inc. | 1,314 | $9.82K | 0.00% |
| California State Teachers Retirement System | 803 | $6.00K | 0.00% |
| Amalgamated Bank | 440 | $3.00K | 0.00% |
| EverSource Wealth Advisors, LLC | 96 | $717 | 0.00% |
| Sterling Capital Management LLC | 31 | $232 | 0.00% |
| FMR LLC | 5 | $37 | 0.00% |
| Avion Wealth | 56 | $0 | 0.00% |
Sold out (8)
Institutions that held Nuvectis Pharma, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Goldman Sachs Group Inc | 45,608 | $445.6K |
| Jane Street Group, LLC | 42,299 | $413.3K |
| Omers Administration Corp | 32,882 | $321.3K |
| Balyasny Asset Management LLC | 13,483 | $131.7K |
| Squarepoint Ops LLC | 11,012 | $107.6K |
| Blue Zone Wealth Advisors, LLC | 10,424 | $101.8K |
| Citadel Advisors LLC | 10,344 | $101.1K |
| Jain Global LLC | 10,154 | $99.2K |